OMNIA BIOSYSTEMS
Omnia Biosystemsâ„¢ is a developer of an artificial intelligence-based drug target discovery platform, BioPATH AI. The BioPATHâ„¢ platform specializes in the discovery of therapeutics for challenging targets.
OMNIA BIOSYSTEMS
Social Links:
Industry:
Artificial Intelligence Biopharma Biotechnology Health Care Life Science Machine Learning Pharmaceutical Therapeutics
Founded:
2021-02-17
Website Url:
http://www.omnia.bio
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Amazon Google Google Cloud Amazon S3 CDN Netlify
Similar Organizations
Biophysical Therapeutics
Computational Biology to Design New Drugs.
Kantify
We develop AI solutions for human life with a focus on healthcare, biotech and mobility.
KYAN Therapeutics
KYAN Therapeutics is a clinical-stage AI company leveraging its proprietary technology platforms to transform the way patients are treated.
Lattice
Redefining laboratory data for Next generation biotechnology
NXT Biologics
NXT Biologics develops therapeutics for lung infections and respiratory illnesses.
OFAI
Help the logistics industry make the most accurate operational decisions with artificial intelligence
Resurgo Genetics
Resurgo Genetics is designing novel, precise interventions into living systems, using unique insights based on two decades of research.
SmartScope
SmartScope focused on bringing early stage malaria diagnoses to the masses.
Well Good
Well Good is a personalised mental health care product that prevents crisis by using data and artificial intelligence at work
Current Employees Featured
Founder
Official Site Inspections
http://www.omnia.bio
- Host name: ec2-18-208-88-157.compute-1.amazonaws.com
- IP address: 18.208.88.157
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Omnia Biosystems"
OmniaBio Announces Opening of New Commercial Manufacturing …
Hamilton, ON., October 17, 2024 – Today OmniaBio Inc. will announce the opening of a new North American cell and gene therapy (CGT) manufacturing and artificial intelligence (AI) …See details»
Omniabio: Road to Canada’s largest cell and gene …
Oct 17, 2024 Transcript | Described Video. New facility opened in October 2024. A subsidiary of the Toronto-based Centre for Commercialization of Regenerative Medicine (CCRM), OmniaBio is Canada’s largest commercial-scale contract …See details»
Funding from Ontario Government for OmniaBio
Mar 31, 2022 Subject to reaching a definitive agreement, OmniaBio Inc. will be the recipient of a loan of up to $40 million from the Government of Ontario, funding that will kickstart the …See details»
OmniaBio Announces Opening of New Commercial …
HAMILTON, ON, Oct. 17, 2024 /CNW/ - Today OmniaBio Inc. will announce the opening of a new North American cell and gene therapy (CGT) manufacturing and artificial intelligence (AI) centre of ...See details»
OmniaBio: Positioning Ontario to lead in a global …
Apr 26, 2023 In September 2022, the industry-led organization behind Canada’s Global Innovation Cluster for Advanced Manufacturing announced it had made a $10.5 million contribution to a $34.8 million project led by OmniaBio, with …See details»
OmniaBio - LinkedIn
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified ...See details»
OmniaBio - Synapse Life Science Consortium
OmniaBio Inc., a subsidiary of Toronto-based CCRM, is a contract development and manufacturing organization (CDMO) producing gene-modified cell therapies and viral vectors, …See details»
OmniaBio Opens New Facility in Canada to Advance …
Oct 30, 2024 OmniaBio Inc. announces the opening of a new North American cell and gene therapy (CGT) manufacturing and artificial intelligence (AI) centre of excellence, which is now Canada’s largest contract development and …See details»
OmniaBio Inc. Launch Announcement - CCRM
OmniaBio will be the first project to be funded by the Government of Ontario via the Invest Ontario Fund, receiving a loan of up to $40 million to enable the construction of a 250,000 ft2 (23,225 m2) contract development and manufacturing organization for cell and gene therapies.See details»
OmniaBio opens largest dedicated cell and gene therapy contract ...
Oct 28, 2024 Contract development and manufacturing organization (CDMO) OmniaBio announced the opening of its new cell and gene therapy (CGT) manufacturing and artificial …See details»
Cell and Gene Therapy CDMO Services - OmniaBio
At the forefront of cell and gene therapy manufacturing, our 120,000 ft² Hamilton facility integrates AI models and advanced technologies designed to increase capacity and meet the evolving …See details»
OmniaBio - The Org
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and …See details»
OmniaBio’s Impact and Future with Mitchel Sivilotti
Apr 27, 2024 Mitch Sivilotti, CEO of OmniaBio Inc., shared with CanadianSME Small Business Magazine how OmniaBio is propelling Canada to the forefront of cell and gene therapy (CGT) …See details»
OmniaBio - Crunchbase Company Profile & Funding
OmniaBio is a contract development and manufacturing organization producing gene-modified cell therapies and viral vectors. It supports a broad range of cell and gene therapy companies from …See details»
omnia.bio
What can you do with Omnia's Discovery Platform? Pre-clinical drug discovery is costly and plagued with inefficiencies. Omnia’s BioPATH AIâ„¢ leverages the power of enabling …See details»
Funding from Ontario government launches OmniaBio Inc.
Development and manufacturing organization (CDMO) for cell and gene therapies (CGTs) – the largest facility of its kind in Canada. “We are grateful to the Government of Ontario, through …See details»
OMNIABIO: POSITIONING ONTARIO TO LEAD IN A GLOBAL
May 4, 2023 In September 2022, the industry-led organization behind Canada’s Global Innovation Cluster for Advanced Manufacturing announced it had made a $10.5 million …See details»
OmniaBio Opens Cell and Gene Therapies Manufacturing Facility …
Oct 18, 2024 OmniaBio Inc. announced the opening of a new North American cell and gene therapy (CGT) manufacturing and artificial intelligence (AI) centre of excellence, which is now …See details»
Invest Ontario supports new biomanufacturing facility in Hamilton
Mar 31, 2022 Project with OmniaBio Inc. drives global leadership in cell and gene therapy. HAMILTON, CANADA (March 31st , 2022) – Invest Ontario is supporting OmniaBio Inc. in …See details»
New survey: U.S. biotechs warn tariffs could impede access to …
2 days ago WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the …See details»